A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474

British Journal of Pharmacology
B N Singh, E M Vaughan Williams

Abstract

1. Both MJ 1999 and AH 3474 protected guinea-pigs anaesthetized with urethane against ouabain-induced ventricular fibrillation.2. MJ 1999 had 1/90, and AH 3474 1/30, of the activity of procaine in reducing the height of the action potential of frog sciatic nerve.3. MJ 1999 and AH 3474 reduced the rate of rise of intracellularly recorded action potentials at concentrations in excess of 160 x 10(-6)M (50 mg/l.). It was concluded that direct depression of depolarization could have contributed little to the protection against ouabain-induced fibrillation.4. MJ 1999, but not AH 3474, greatly prolonged the duration of the action potential in acute experiments on isolated atrial and ventricular muscle, and prolonged the Q-Tc interval of the electrocardiogram in anaesthetized guinea-pigs. It is suggested that this effect contributes to anti-arrhythmic activity.5. At concentrations up to 80 x 10(-6)M AH 3474 had positive chronotropic and inotropic effects on isolated rabbit atrial muscle, but at higher concentrations these were superseded by negative effects. MJ 1999 was depressant at all concentrations studied, the threshold concentrations being 19 x 10(-6)M for chronotropic, and 162 x 10(-6)M for inotropic effects.

References

Feb 10, 1967·Annals of the New York Academy of Sciences·J R Blinks
Aug 1, 1969·The Journal of Pharmacy and Pharmacology·C H BlackburnG P Levy
May 1, 1970·British Journal of Pharmacology·J M Kofi EkueR G Shanks
Jul 1, 1970·Circulation·H BrooksL Dexter
Jan 1, 1970·Advances in Cardiology·E M Vaughan Williams
Feb 10, 1967·Annals of the New York Academy of Sciences·E J Ariëns
Oct 1, 1969·European Journal of Pharmacology·N SvedmyrR Malmberg
Aug 1, 1970·British Journal of Pharmacology·B N Singh, E M Vaughan Williams
Apr 1, 1970·The Journal of Physiology·A S FreedbergE M Williams
Aug 1, 1968·The American Journal of Cardiology·W S Frankl, L A Soloff
Aug 1, 1968·European Journal of Pharmacology·C Raper, J L Wale
Jun 1, 1969·British Journal of Pharmacology·A N DohadwallaE M Vaughan Williams

Citations

Mar 1, 1994·Clinical Cardiology·J A ReiffelR DiBianco
Aug 1, 1979·Journal of Clinical Pharmacology·A Simon, E Berman
Nov 1, 1991·Journal of Clinical Pharmacology·M D Freedman, J C Somberg
Dec 1, 1991·Cardiovascular Drugs and Therapy·H M HoffmeisterL Seipel
Jun 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·G Scholtysik
Jan 1, 1990·European Journal of Clinical Pharmacology·J M PoirierG Cheymol
Jun 1, 1990·Cardiovascular Drugs and Therapy·B N Singh
Jun 1, 1990·Cardiovascular Drugs and Therapy·R N Millar
Jan 1, 1981·European Journal of Clinical Pharmacology·P J NeuvonenM Laakso
Oct 1, 1989·Cardiovascular Drugs and Therapy·B N Singh
Apr 1, 1989·Cardiovascular Drugs and Therapy·L J JordaensD L Clement
Oct 1, 1990·Cardiovascular Drugs and Therapy·H J TrappeP Lichtlen
Sep 3, 2008·European Journal of Clinical Pharmacology·Juan Carlos Estrada, Dawood Darbar
Feb 1, 1985·American Heart Journal·Dan M Roden, R L Woosley
Jul 1, 1971·European Journal of Pharmacology·B Spilker, S Shevde
Feb 1, 1974·European Journal of Pharmacology·E M Vaughan Williams, P Polster
Nov 1, 1974·European Journal of Pharmacology·E J Mylecharane, C Raper
Apr 1, 1975·European Journal of Pharmacology·J F GiudicelliJ R Boissier
Nov 1, 1975·European Journal of Pharmacology·B N SinghR M Whitlock
Sep 1, 1976·European Journal of Pharmacology·N Goupil, J Lenfant
Jun 1, 1979·European Journal of Pharmacology·T ShimizuS Shibata
May 14, 1992·European Journal of Pharmacology·M GwiltA M Solca
Sep 19, 1996·European Journal of Pharmacology·A YoshidaC Shigemasa
Jan 1, 1982·Pharmacology & Therapeutics·R S Bexton, A J Camm
Jan 1, 1984·Pharmacology & Therapeutics·E Winslow
Jan 1, 1988·Pharmacology & Therapeutics·J W UpwardC F George
Jan 1, 1975·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·E M Vaughan Williams
Apr 1, 1988·Journal of the American College of Cardiology·R TakikawaB N Singh
Apr 1, 1989·Journal of the American College of Cardiology·S NattelM Talajic
Feb 1, 1989·Journal of the American College of Cardiology·W G StevensonD Wohlgelernter
Jan 1, 1989·Journal of the American College of Cardiology·M A RuderR A Winkle
Jun 1, 1993·Journal of the American College of Cardiology·S A Guidera, J S Steinberg
Sep 1, 1995·Journal of the American College of Cardiology·F Chézalviel-GuilbertJ Weissenburger
Mar 15, 2005·European Journal of Pharmacology·Péter BiliczkiA Varró
Nov 14, 1997·The American Journal of Cardiology·B N Singh
Nov 24, 1999·The American Journal of Cardiology·B N SinghJ S Sarma
Jun 23, 2000·European Journal of Pharmacology·T D BarrettM J Walker
May 1, 1995·Progress in Cardiovascular Diseases·E Cavusoglu, W H Frishman
Aug 22, 1981·Lancet·P J NeuvonenJ Tuomilehto
May 8, 2001·Trends in Pharmacological Sciences·Jamie I VandenbergT J Campbell
Jul 1, 1987·Journal of the American College of Cardiology·J M McCombH Garan
Dec 1, 1988·Journal of the American College of Cardiology·R GonzalezH Sharkey
May 1, 1988·Journal of the American College of Cardiology·S M YabekB N Singh
Jul 7, 1994·The New England Journal of Medicine·S H Hohnloser, R L Woosley
May 6, 2005·The New England Journal of Medicine·B N SinghSotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators
Apr 1, 1972·British Journal of Pharmacology·C AdvenierJ F Giudicelli
Nov 1, 1995·Pacing and Clinical Electrophysiology : PACE·S IsomotoK Yano
Feb 1, 1993·Journal of Cardiovascular Electrophysiology·R Ruffy
Jun 2, 1998·Journal of Cardiovascular Electrophysiology·F Chézalviel-GuilbertJ Weissenburger
Nov 1, 1990·Pharmacology & Toxicology·E MortensenH Refsum
Apr 1, 1996·The Journal of Pharmacy and Pharmacology·M J HagertyK A Kane
May 5, 1979·British Medical Journal·E ElonenR Kala
Aug 6, 1983·British Medical Journal·R MaheswaranC A Hardisty
Jun 1, 1981·British Heart Journal·N Edvardsson, S B Olsson
Jun 1, 1982·British Heart Journal·A W NathanA J Camm
Jun 1, 1982·British Heart Journal·D H Bennett
Feb 1, 1984·British Heart Journal·J K McKibbinI W Obel
May 1, 1981·Postgraduate Medical Journal·A KontopoulosP Metaxas
May 16, 2009·Drugs·Joachim R Ehrlich, S Nattel
Apr 1, 2014·The Journal of Physiological Sciences : JPS·Linyuan JingAbhijit Patwardhan
Nov 1, 1989·Medical Toxicology and Adverse Drug Experience·F A Fish, Dan M Roden
Sep 8, 2006·Current Cardiology Reports·B N Singh
May 13, 2009·Expert Opinion on Drug Safety·Knut Gjesdal
Nov 4, 2000·Expert Opinion on Investigational Drugs·S A Doggrell, L Brown
Jan 1, 1984·Journal of Toxicology. Clinical Toxicology·D de WildtG de Groot
Jul 24, 2013·The Journal of Physiology·Norbert JostS Nattel
Mar 23, 2011·Pharmacology & Therapeutics·Jérôme ThireauSylvain Richard
Jun 5, 2016·Cardiac Electrophysiology Clinics·Vincent Algalarrondo, S Nattel
Dec 1, 1980·American Heart Journal·D E Jewitt
Oct 15, 1989·The American Journal of Cardiology·S N SinghR D Fletcher
Nov 26, 1993·The American Journal of Cardiology·S Nattel
Jan 1, 1989·Progress in Cardiovascular Diseases·A Kadish, F Morady
Mar 14, 1970·Lancet·B N Singh
Nov 1, 1982·The American Journal of Cardiology·D S EchtJ W Mason
Aug 1, 1982·Clinical Physiology·O KristiansenR Hotvedt
Mar 1, 1974·American Heart Journal·B N Singh, O Hauswirth
Sep 1, 1988·The American Journal of Cardiology·S N SinghR D Fletcher
Feb 24, 2006·Journal of Pharmacological Sciences·Hiroyuki SasakiKeiji Yamamoto
Jun 5, 2016·Cardiac Electrophysiology Clinics·John Alvin Kpaeyeh, John Marcus Wharton
Nov 1, 1984·The American Journal of Emergency Medicine·A Heath
Sep 1, 1987·American Heart Journal·P TouboulA Dellinger
Apr 1, 1992·American Heart Journal·E MortensenH Refsum
Mar 1, 1995·Pacing and Clinical Electrophysiology : PACE·J P Claudel, P Touboul
Feb 22, 2017·Frontiers in Pharmacology·Hrayr S KaragueuzianRiccardo Olcese
Jun 17, 2003·Journal of Cardiovascular Pharmacology and Therapeutics·B N Singh
Dec 20, 2002·Journal of Cardiovascular Pharmacology and Therapeutics·B N SinghJonnalagedda S M Sarma
Oct 8, 2005·Journal of Cardiovascular Pharmacology and Therapeutics·Nitin Wadhani, B N Singh
Jul 14, 2001·Journal of Cardiovascular Pharmacology and Therapeutics·B N Singh, J S Sarma
Jun 21, 2005·Journal of Cardiovascular Pharmacology and Therapeutics·B N Singh
May 15, 2003·Journal of Cardiovascular Pharmacology and Therapeutics·B N Singh
Sep 21, 2004·Journal of Cardiovascular Pharmacology and Therapeutics·B N Singh, Nitin Wadhani
Dec 18, 2003·Journal of Cardiovascular Electrophysiology·Dan M Roden
Dec 12, 2001·Pediatrics International : Official Journal of the Japan Pediatric Society·A CelikerS Ozme
May 1, 1982·Clinical Cardiology·A J CammV B Whitmarsh
May 1, 1987·Circulation·K P KunzeK H Kuck
Feb 13, 2015·Circulation. Arrhythmia and Electrophysiology·Di LangIgor R Efimov
Oct 9, 2008·Journal of Cardiovascular Pharmacology·B N Singh
Oct 21, 2016·American Journal of Therapeutics·Sahan P Semasinghe BandaralageSelvanayagam Niranjan
Sep 1, 1989·Pacing and Clinical Electrophysiology : PACE·M Wang, P Dorian
Jan 13, 2006·British Journal of Pharmacology·M J A Walker
Jan 14, 2020·Journal of Cardiovascular Electrophysiology·Christopher L-H HuangMing Lei
Mar 1, 1997·Journal of Cardiovascular Pharmacology·V KühlkampL Seipel
Apr 30, 2003·Journal of Cardiovascular Pharmacology·Akiko Shiroshita-TakeshitaSatoshi Ogawa
Feb 1, 1971·British Journal of Pharmacology·J M Layman, A S Milton
Mar 25, 1999·Journal of Cardiovascular Electrophysiology·B N Singh
Feb 23, 2000·Journal of Cardiovascular Pharmacology and Therapeutics·B N Singh
Aug 3, 2001·Cardiovascular Drug Reviews·M Manoach, N Tribulova
Apr 1, 1984·Journal of Clinical Pharmacology·E M Vaughan Williams
Feb 23, 2000·Journal of Cardiovascular Pharmacology and Therapeutics·M Valderrábano, B N Singh
Feb 23, 2000·Journal of Cardiovascular Pharmacology and Therapeutics·P C Deedwania
Sep 20, 2012·Physiological Reviews·Jamie I VandenbergAdam P Hill
Apr 1, 1973·The Journal of Pharmacy and Pharmacology·M K Lavender, M W Parkes
May 16, 1988·Klinische Wochenschrift·H M Hoffmeister, L Seipel
Jul 1, 1979·Acta Pharmacologica Et Toxicologica·P J NeuvonenL Tarssanen
Feb 23, 2000·Journal of Cardiovascular Pharmacology and Therapeutics·M NémethJ G Papp
Jan 1, 1996·Journal of Cardiovascular Pharmacology and Therapeutics·K NademaneeG K Feld
Apr 1, 1996·Journal of Cardiovascular Pharmacology and Therapeutics·D A LathropA Schwartz
Oct 1, 1996·Journal of Cardiovascular Pharmacology and Therapeutics·B N Singh
Jan 1, 1996·Journal of Cardiovascular Pharmacology and Therapeutics·F SakaiM Hiraoka
Apr 1, 1997·Journal of Cardiovascular Pharmacology and Therapeutics·D GallikB N Singh
Dec 17, 2003·Pacing and Clinical Electrophysiology : PACE·Dan M Roden
Apr 30, 2011·Journal of Cardiovascular Pharmacology and Therapeutics·John C SombergJanos Molnar
Aug 30, 2018·BioMed Research International·Dina S KondratievaSergey V Popov
Oct 1, 1984·Scottish Medical Journal·J M Beattie
Jan 1, 1997·Journal of Cardiovascular Pharmacology and Therapeutics·B N Singh
Jan 1, 1982·British Journal of Clinical Pharmacology·J F Giudicelli, F Lhoste
Apr 1, 1996·Journal of Cardiovascular Pharmacology and Therapeutics·S Chun, B N Singh
Jan 1, 1982·Acta Medica Scandinavica. Supplementum·K J TöttermanT Pellinen
Jul 2, 1990·The Medical Journal of Australia·D L RossJ B Uther
Sep 20, 2007·Journal of Cardiovascular Pharmacology·Eugene PattersonK Darrell Berlin

Related Concepts

Nerve Impulses
Anilides
Metazoa
Cardiac Depressants
Salientia
Felis catus
Depression, Chemical
Electrocardiographic Recorders
Cavia porcellus
Heart

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.